Cardiac Metastases of Recurrent Infiltrating Amelanotic Fusocellular Malignant Melanoma: Case Report
Main Article Content
Abstract
Melanoma is one of the most aggressive types of skin cancer. The malignant amelanotic fusocellular melanoma subtype is an uncommon presentation, however, it has a high rate of cardiac involvement, it presents asymptomatic or with symptoms ranging from nonspecific to cardiac tamponade or heart failure. We present a case of a 48-year-old man with recurrent infiltrating amelanotic fusocellular malignant melanoma, with incidentally visualized biventricular lesion and right atrium, with cardiac tamponade with subsequent fluoroscopy-guided pericardiocentesis. Primary cardiac tumors have a prevalence of 1:2000 autopsies and secondary cardiac tumors of 1:100 autopsies, remaining as a secondary: primary ratio of 20:1. In patients with this type of melanoma, although cardiac metastases are common, the diagnosis of them is rare, when it occurs, the disease is very advanced and the treatment is usually palliative.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Xu Z, Shi P, Yibulayin F, Feng L, Zhang H, Wushou A. Spindle cell melanoma: Incidence and survival, 1973-2017. Oncol Lett. 2018 Oct; 16(4):5091-5099. doi: 10.3892/ol.2018.9247. Epub 2018 Aug 1. PMID: 30250577; PMCID: PMC6144801.
II. Long AS, Chang J, Glahn JZ, Olino K, Tran TT, Clune J. Current diagnosis and management of cardiac melanoma: a case series and review. Journal of Cancer Metastasis and Treatment. 2023; 9: 27. http://dx.doi.org/10.20517/2394-4722.2022.113
III. Brusca RM, Griffin JM, Miller K, Russell SD. Metastatic amelanotic melanoma with cardiac involvement: A case report. J Cardiol Cases. 2018 Nov 10;19(2):59-61.
doi: 10.1016/j.jccase.2018.10.006. PMID: 31193670; PMCID: PMC6538597.
IV. Dhanyamraju PK, Patel TN. Melanoma therapeutics: a literature review. J Biomed Res. 2022 Feb 28;36(2):77-97. doi: 10.7555/JBR.36.20210163. PMID: 35260531; PMCID: PMC9002155.
V. Osama MA, Rao S, Bakshi N, Badwal S, Aggarwal S. Amelanotic Melanoma: A Great Masquerader. J Lab Physicians. 2022 Oct 20;15(2):300-305. doi: 10.1055/s-0042-1757236. PMID: 37323600; PMCID: PMC10264121.
VI. Mitamura Y, Ito T, Nakano-Nakamura M, Uchi H, Furue M. S100A6 and c-Kit-Positive Spindle Cell Melanoma of the Dorsal Foot. Case Rep Dermatol. 2014 May 16;6(2):140-4. doi: 10.1159/000363097. PMID: 24932168; PMCID: PMC4049021
VII. J. M. YOUNG and I. RALPH GOLDMAN. Tumor Metastasis to the Heart. Circulation. 1954;9:220–229. https://doi.org/10.1161/01.CIR.9.2.220
VIII. Balinski AM, Vasbinder AL, Kerndt CC, Catalan TC, Parry NP, Rehman RA, Blakely P, Yeow RY, Leja MJ, Lao CD, Fecher LA, Hayek SS. Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes. Cancer Med. 2023 Feb;12(3):2356-2367. doi: 10.1002/cam4.5058. Epub 2022 Jul 27. PMID: 35894689; PMCID: PMC9939187.
IX. Alexander M. Balinski, Connor C. Kerndt, Nathan P. Parry, Rafey A. Rehman, Raymond Y. Yeow, and Salim S. Hayek. Metastatic Melanoma of the Heart: A Systematic Review. Journal of Clinical Oncology 2020.
DOI: 10.1200/JCO.2020.38.15_suppl.e22017
X. Bussani, R., Castrichini, M., Restivo, L. et al. Cardiac Tumors: Diagnosis, Prognosis, and Treatment. Curr Cardiol Rep 22, 169 (2020).
https://doi.org/10.1007/s11886-020-01420-z
XI. Messner G, Harting MT, Russo P, Gregoric ID, Mukhopadhyay M, Flamm SD, Frazier OH. Surgical management of metastatic melanoma to the ventricle. Tex Heart Inst J. 2003;30(3):218-20. PMID: 12959206; PMCID: PMC197321.